AMARIN CORP PLC\UK — Director's Dealing 2012

Apr 26, 2012

SEC Form 4/A — Form 4/A

Issuer: AMARIN CORP PLC\UK (AMRN)
CIK: 0000897448
Period of Report: 2012-04-17

Reporting Person: Abingworth LLP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-04-17	Ordinary Shares, 50 pence par value per share	S	1712000	$9.6111	Disposed	3895509	Indirect
2012-04-18	Ordinary Shares, 50 pence par value per share	S	1614341	$9.6049	Disposed	2281168	Indirect
2012-04-19	Ordinary Shares, 50 pence par value per share	S	682000	$9.6574	Disposed	1599168	Indirect

Footnotes

F1: Abingworth LLP (the "Reporting Person") is the investment manager to a number of investment funds that include Abingworth Bioventures V L.P. ("ABV V"), Abingworth Bioventures V Co-Invest Growth Equity Fund LP ("AGE"), and Abingworth Bioequities Master Fund Limited ("ABE," and collectively with ABV V and AGE, the "Abingworth Funds"). On April 17, 2012, ABV V sold 760,128 ordinary shares, 50 pence par value per share, of Amarin Corporation plc ("Ordinary Shares"), AGE sold 760,128 Ordinary Shares, and ABE sold 191,744 Ordinary Shares. On April 18, 2012, ABV V sold 716,767 Ordinary Shares, AGE sold 716,767 Ordinary Shares, and ABE sold 180,807 Ordinary Shares. On April 19, 2012, ABV V sold 302,808 Ordinary Shares, AGE sold 302,808 Ordinary Shares, and ABE sold 76,384 Ordinary Shares.

F2: The Reporting Person may be deemed to beneficially own the Ordinary Shares reported herein indirectly through the Abingworth Funds. The Reporting Person's interest in the securities reported herein is limited to the extent of its pecuniary interest, if any, in the Abingworth Funds. This report shall not be deemed an admission that the Reporting Person, each Abingworth Fund or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.